Skip to main content
. Author manuscript; available in PMC: 2009 Oct 13.
Published in final edited form as: Expert Rev Clin Pharmacol. 2008 May 1;1(3):391–400. doi: 10.1586/17512433.1.3.391

Table 3.

Fitting a mixed Cox-Aalen model, the predicted CIF (SE) of TRM for a 35 years old patient and received a Non-T-cell depleted marrow transplant for GVHD prophylaxis by low and high platelet counts.

Time Low Platelet Counts High Platelet Counts
1yr 0.42 (0.03) 0.26 (0.04)
3yr 0.46 (0.03) 0.32 (0.05)